Form 8-K - Current report:
SEC Accession No. 0001140361-24-013726
Filing Date
2024-03-18
Accepted
2024-03-18 08:56:42
Documents
16
Period of Report
2024-03-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20024275_8k.htm   iXBRL 8-K 36492
2 EXHIBIT 99.1 ef20024275_ex99-1.htm EX-99.1 17010
7 image00001.jpg GRAPHIC 4628
  Complete submission text file 0001140361-24-013726.txt   252569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20240318.xsd EX-101.SCH 4696
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20240318_def.xml EX-101.DEF 18374
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20240318_lab.xml EX-101.LAB 27789
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20240318_pre.xml EX-101.PRE 20673
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20024275_8k_htm.xml XML 8285
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 24757039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)